Idiopathic Midline Destructive Disease (IMDD): A Subgroup of Patients with the “Midline Granuloma” Syndrome
1982; Oxford University Press; Volume: 77; Issue: 2 Linguagem: Inglês
10.1093/ajcp/77.2.162
ISSN1943-7722
AutoresMaria Tsokos, Anthony S. Fauci, J.J.N. Costa,
Tópico(s)Sarcoidosis and Beryllium Toxicity Research
ResumoJournal Article Idiopathic Midline Destructive Disease (IMDD): A Subgroup of Patients with the "Midline Granuloma" Syndrome Get access Maria Tsokos, M.D., Maria Tsokos, M.D. Laboratory of Pathology, Division of Cancer Biology and Diagnosis, National Cancer Institute and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland Search for other works by this author on: Oxford Academic Google Scholar Anthony S. Fauci, M.D., Anthony S. Fauci, M.D. Laboratory of Pathology, Division of Cancer Biology and Diagnosis, National Cancer Institute and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland Search for other works by this author on: Oxford Academic Google Scholar Jose Costa, M.D. Jose Costa, M.D. Laboratory of Pathology, Division of Cancer Biology and Diagnosis, National Cancer Institute and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland Search for other works by this author on: Oxford Academic Google Scholar American Journal of Clinical Pathology, Volume 77, Issue 2, 1 February 1982, Pages 162–168, https://doi.org/10.1093/ajcp/77.2.162 Published: 01 February 1982 Article history Received: 26 March 1981 Accepted: 16 June 1981 Published: 01 February 1982
Referência(s)